Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boston Bags Assets From GSK and Novartis

Oct 03 2018

• By Kevin Grogan

Gold — Boston pans for gold among big pharma portfolios • Source: Shutterstock

Related Content

Walmsley Shakes Up GSK; Cuts More Than 30 Drug Development Programs

Jul 26 2017

Roivant Splashes Cash Again To License GSK Skin Disorder Drug

Jul 13 2018

Related Companies

Boston Pharmaceuticals Inc.

GSK plc

Novartis AG

Roivant Sciences Ltd.

Novo Nordisk A/S

Eli Lilly and Company

Sanofi

AstraZeneca PLC

Daiichi Sankyo Co., Ltd.

Additional Topics

Deals Commercial Infectious Diseases Gastrointestinal Dermatology BioPharmaceutical

More from Anti-infective

More from Therapeutic Category

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.